Poly-MVA is a promising integrative cancer therapy, used in the United States since 1992. This nutraceutical contains a powerful blend of ingredients, including alpha lipoic acid (a powerful anti-oxidant), palladium (a trace mineral), N-acetyl cysteine (anti-oxidant), vitamin B1 (thiamine), vitamin B2 (riboflavin), and vitamin B12 (cobalamin).
It works as a redox molecule, which simply means that it can accept an electrical charge from one entity and then donate that charge to another entity where it is needed. This process is key in addressing free radical damage in the body. The alpha lipoic acid and minerals in Poly-MVA bind to one another, and are able to travel throughout the body due to being both water-soluble and fat-soluble.
How Poly-MVA is thought to work against cancer cells
Research has shown that cancer cells thrive in low oxygen environments. Poly-MVA has shown the ability to target mitochondria in cancer cells, which interferes with cancer cells’ ability to produce energy. It is also thought to negatively affect cancer cell genes, and thus, possibly counteract the DNA alterations we see in cancer.
Poly-MVA’s impact on healthy cells
Poly-MVA is that it has not been shown to harm normal, healthy cells. In fact, studies suggest that it results in increased ATP (energy) in normal cells due to increased oxygen levels. It has no known side effects, and acts in the body as a food.
How Dr. Stegall uses Poly-MVA in cancer
Dr. Stegall uses Poly-MVA in intravenous (IV) form as well as orally in his protocols. This combination allows for efficient uptake into the cells where it is needed most.